Solvay's stock shows a 4.29% increase at midday this Wednesday, trading at 26.26 euros after closing the previous day at 25.18 euros. This surge comes amid a generalized rebound of European indices, with the CAC 40 up 1.38% during the session. The Belgian chemical company is recovering after a significant downtrend over the past year.
Solvay Stock Benefits from a Strong Upward Movement
This Wednesday, Solvay's stock is benefiting from a clear upward movement, bringing its price above the 20-day moving average (26.15 euros), which it had lost in recent sessions. However, the stock remains below its 50-day moving average at 26.44 euros, which poses an immediate technical barrier. The RSI, at 43, indicates the stock is still in a zone of relative weakness, suggesting there is room for growth before reaching overbought levels.
This rebound is part of the positive momentum observed in European markets since the announcement on March 23 by Donald Trump of a de-escalation between Washington and Tehran around the Strait of Hormuz. Although the situation remains fragile, the postponement of American strikes and the resumption of dialogue have helped the CAC 40 recover after a very volatile session at the beginning of the week. The SBF 120 is also up 1.38% in the session. However, Solvay's recent performance remains fragile: the stock has declined by 1.57% over seven days and 21.61% over the year, indicating a deep-seated bearish trend that has not yet reversed.
Busy Financial Calendar Ahead for Solvay
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Solvay's financial calendar looks busy in the coming weeks. The publication of the first quarter 2026 results is scheduled for May 7, followed by the annual general meeting on May 12. These events will provide insights into the operational trajectory of the group after a year marked by a significant decline in share price.
From a technical standpoint, the major resistance is at 28.50 euros, approximately 8.5% above the current price. The identified support at 24.50 euros held during the recent downturn, providing a reference floor for traders. The nearly zero beta (-0.06) of the stock indicates a low correlation with major indices, a characteristic sometimes sought in times of uncertainty. Monthly volatility remains contained at 8.17%, contrasting with the tensions observed on the VIX, which was at 26.78 in its last available measurement. However, the approach of the quarterly publication could revive fluctuations in the stock in the coming weeks.
Challenging market environment, excluding potential recovery measures from Sadara, updated guidance reflects Middle East impact
Risks mentioned
Middle East conflict impact of approximately €-25 million on underlying EBITDA in Q3 2026
Continued shutdown of the Peroxide plant at the Sadara complex in Jubail, Saudi Arabia accounted for €-15 million in Q3 2026
Challenging market environment affecting Group performance in Q3 2026
Opportunities identified
Joint venture contractual framework includes mechanisms designed to recover lost profitability from Sadara shutdown
Group exploring all available avenues to mitigate financial impact of shutdown
Transformation program and focus on cash generation and cost savings targets
Outlook / guidance
Expected EBITDA: 730 millions d'euros
Management commentary: In light of these developments, Solvay has reviewed its full-year 2026 guidance. Excluding potential revenue or recovery measures from Sadara for the remainder of 2026, the updated guidance is: Underlying EBITDA between €720 and €740 million
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.